Omnicell (OMCL) Trading Up 20% After Beating EPS View And Receiving An Upgrade
Tweet
Share
E-mailGet Alerts OMCL Hot Sheet
Price: $37.30 -0.9%
Financial Fact:
Cost of services and other revenues: 19.04M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Cost of services and other revenues: 19.04M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Omnicell (Nasdaq: OMCL) is trading up 20% after beating the Q1 EPS view of $0.06 by a penny. Revenue for the quarter was $52.2 million, versus the consensus of $48.89 million.
Omnicell also received an upgrade from Auriga from Hold to Buy this morning.
Subscribe to EasyStockAlerts.com & Get real-time e-mail alerts when news hits your stocks!
Omnicell is a leading provider of system solutions to acute healthcare facilities, today announced results for its first quarter ended March 31, 2009.
Omnicell also received an upgrade from Auriga from Hold to Buy this morning.
Subscribe to EasyStockAlerts.com & Get real-time e-mail alerts when news hits your stocks!
Omnicell is a leading provider of system solutions to acute healthcare facilities, today announced results for its first quarter ended March 31, 2009.
You May Also Be Interested In
- U.S. Physical Therapy names Nchacha Etta as CFO, effective Sept. 2026
- Avalonbay Communities (AVB) dropped from S&P 500
- Stripe, Advent In Talks To Buy Paypal - WSJ
Create E-mail Alert Related Categories
Earnings, Insiders' Blog, Trader TalkRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
